FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets, Authority Hl7

17,520 resources

Source: Text:

By Version

By Realm

 

Start Prev Rows 5600 - 5800 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmSource(s)
us.nlm.vsacR42.16.840.1.113883.3.464.1003.106.12.1001Substance Use Disorderactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.106.12.1005Substance Use Disorder Treatmentactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1060Desiccated Thyroid Medicationsactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1062Potentially Harmful Skeletal Muscle Relaxants for Older Adultsactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1063Potentially Harmful Pain Medications for Older Adultsactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1065Digoxin Medicationsactive2021-09usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1066Digoxin Medicationsactive2024-01usrx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1067Doxepin Medicationsactive2021-09usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1068Doxepin Medicationsactive2021-09usrx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.108.11.1001Malignant Neoplasm of Colonactive2024-11ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.108.11.1003Malignant Neoplasm of Colonactive2023-02usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.108.11.1025Malignant Neoplasm of Lymphatic and Hematopoietic Tissueactive2024-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.108.11.1027Malignant Neoplasm of Lymphatic and Hematopoietic Tissueactive2022-02usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.108.11.1044Pap Testactive2017-05usloinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.108.11.1047Mammographyactive2024-11usloinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.108.11.1051Colonoscopyactive2023-11uscpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.108.11.1052Colonoscopyactive2017-12uscms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.108.11.1053Colonoscopyactive2025-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.108.11.1145sDNA FIT Testactive2017-12usloinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.108.12.1001Malignant Neoplasm of Colonactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.108.12.1009Malignant Neoplasm of Lymphatic and Hematopoietic Tissueactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.108.12.1017Pap Testactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.108.12.1018Mammographyactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.108.12.1020Colonoscopyactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.108.12.1038CT Colonographyactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.108.12.1039sDNA FIT Testactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.109.11.1024Kidney Transplantactive2021-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.109.11.1025Kidney Transplantactive2021-02uscpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.109.11.1026Dialysis Servicesactive2021-02uscpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.109.11.1027Dialysis Servicesactive2021-02uscms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.109.11.1028Dialysis Servicesactive2017-05ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.109.11.1029ESRD Monthly Outpatient Servicesactive2017-08uscpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.109.11.1052Kidney Transplantactive2017-05uscms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.109.11.1060Kidney Transplant Recipientactive2019-03usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.109.11.1067Kidney Transplantactive2019-03uscms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.109.12.1012Kidney Transplantactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.109.12.1013Dialysis Servicesactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.109.12.1014ESRD Monthly Outpatient Servicesactive2017-05usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.109.12.1029Kidney Transplant Recipientactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1065DTaP Vaccine Administeredactive2021-09uscpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1066DTaP Vaccine Administeredactive2024-11ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1068Hepatitis Aactive2019-03ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1070Hepatitis Aactive2017-05usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1078Measlesactive2021-09ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1080Measlesactive2017-05usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1085Measles, Mumps and Rubella (MMR) Vaccine Administeredactive2017-05uscpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1086Measles, Mumps and Rubella (MMR) Vaccine Administeredactive2023-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1087Mumpsactive2023-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1089Mumpsactive2017-05usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1098Rubellaactive2021-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.110Rubellaactive2017-05usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1104Varicella Zosteractive2017-05usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1105Varicella Zosteractive2025-01ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1106Varicella Zoster Vaccine (VZV) Administeredactive2017-05uscpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1107Varicella Zoster Vaccine (VZV) Administeredactive2023-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1109Hepatitis A Vaccine Administeredactive2017-05uscpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1110Hepatitis A Vaccine Administeredactive2024-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1111Hepatitis B Vaccine Administeredactive2021-09uscpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1112Hepatitis B Vaccine Administeredactive2023-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1115Child Influenza Vaccine Administeredactive2023-02uscpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1116Child Influenza Vaccine Administeredactive2023-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1117Inactivated Polio Vaccine (IPV) Administeredactive2021-09uscpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1118Inactivated Polio Vaccine (IPV) Administeredactive2023-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1119Pneumococcal Conjugate Vaccine Administeredactive2023-11uscpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1120Rotavirus Vaccine (3 dose schedule) Administeredactive2017-05uscpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1121Rotavirus Vaccine (2 dose schedule) Administeredactive2017-05uscpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1123Genital Herpesactive2024-03usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1124Genital Herpesactive2024-03ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1128Lab Tests for Sexually Transmitted Infectionsactive2022-02usloinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1129Chlamydia Screeningactive2024-02usloinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1133Pneumococcal Conjugate Vaccine Administeredactive2024-11ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1135HPV Testactive2024-11usloinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1148Rotavirus Vaccine (2 Dose Schedule) Administeredactive2019-03ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1149Rotavirus Vaccine (3 Dose Schedule) Administeredactive2019-03ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1150Advanced Illnessactive2025-02usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1151Advanced Illnessactive2025-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1152HiB Vaccine (3 dose schedule)active2021-12uscvx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1153HiB Vaccine (3 dose schedule) Administeredactive2021-09uscpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1154HiB Vaccine (4 dose schedule)active2021-09uscvx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1155HiB Vaccine (4 dose schedule) Administeredactive2021-09uscpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1156HiB Vaccine (3 dose schedule) Administeredactive2024-03ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1157HiB Vaccine (4 dose schedule) Administeredactive2024-03ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1158Competing Conditions for Respiratory Conditionsactive2024-02usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.11.1159Competing Conditions for Respiratory Conditionsactive2023-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1022DTaP Vaccine Administeredactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1024Hepatitis Aactive2017-05usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1031Measles, Mumps and Rubella (MMR) Vaccine Administeredactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1032Mumpsactive2017-05usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1037Rubellaactive2017-05usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1039Varicella Zosteractive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1040Varicella Zoster Vaccine (VZV) Administeredactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1041Hepatitis A Vaccine Administeredactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1042Hepatitis B Vaccine Administeredactive2022-09usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1044Child Influenza Vaccine Administeredactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1045Inactivated Polio Vaccine (IPV) Administeredactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1046Pneumococcal Conjugate Vaccine Administeredactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1047Rotavirus Vaccine (3 dose schedule) Administeredactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1048Rotavirus Vaccine (2 dose schedule) Administeredactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1049Genital Herpesactive2018-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1051Lab Tests for Sexually Transmitted Infectionsactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1052Chlamydia Screeningactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1053Measlesactive2017-05usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1059HPV Testactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1082Advanced Illnessactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1083Hib Vaccine (3 dose schedule)active2019-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1084Hib Vaccine (3 dose schedule) Administeredactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1085Hib Vaccine (4 dose schedule)active2019-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1086Hib Vaccine (4 dose schedule) Administeredactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1087Influenza Virus LAIV Vaccineactive2021-02usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.110.12.1088Influenza Virus LAIV Vaccine Administeredactive2021-02usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.11.1012Lab Tests During Pregnancyactive2023-02usloinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.11.1013Diagnostic Studies During Pregnancyactive2022-02usloinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.11.1019Pregnancy Testactive2023-02usloinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.11.1022Complications of Pregnancy, Childbirth and the Puerperiumactive2024-02usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.11.1023Complications of Pregnancy, Childbirth and the Puerperiumactive2023-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.11.1028Procedures for Sexual Activityactive2024-02uscpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.11.1030Procedures for Sexual Activityactive2024-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.11.1031Diagnosis for Sexual Activityactive2021-02usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.11.1032Diagnosis for Sexual Activityactive2024-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.11.1033Procedures for Sexual Activityactive2021-02uscms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.12.1007Lab Tests During Pregnancyactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.12.1008Diagnostic Studies During Pregnancyactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.12.1011Pregnancy Testactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.12.1012Complications of Pregnancy, Childbirth and the Puerperiumactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.12.1016Congenital or Acquired Absence of Cervixactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.12.1017Procedures Used to Indicate Sexual Activityactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.12.1018Diagnoses Used to Indicate Sexual Activityactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.112.11.1024Absence of Cervixactive2021-02usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.112.11.1025Absence of Cervixactive2021-09ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.112.11.1026Absence of Cervixactive2023-09usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1073Osteoporosis Without Current Fractureactive2017-12usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1074Osteoporosis Without Current Fractureactive2023-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1200Osteoporosis With Current Fractureactive2024-02usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1201Osteoporosis With Current Fractureactive2024-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1202DXA (Dual energy Xray Absorptiometry) Scan Non Hip or Spineactive2021-02usloinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1308Frailty Diagnosisactive2024-11usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1309Frailty Diagnosisactive2025-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1310Frailty Symptomactive2023-02usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1311Frailty Symptomactive2023-11ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1038Osteoporosis Without Current Fractureactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1050Osteoporosis With Current Fractureactive2018-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1051DXA (Dual energy Xray Absorptiometry) Scanactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1074Frailty Diagnosisactive2019-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1075Frailty Symptomactive2019-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.114.11.1021Narcolepsyactive2018-08ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.114.11.1023Narcolepsyactive2017-05usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.114.11.1024Neurologic impairmentactive2024-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.114.11.1025Neurologic impairmentactive2017-05usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.114.11.1026Neurologic impairmentactive2021-09usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.114.12.1011Narcolepsyactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.114.12.1012Neurologic impairmentactive2024-02usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1149Substance Use Disorder Long Acting Medicationactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.115.11.1248Retinal or Dilated Eye Examactive2025-01ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.115.12.1088Retinal or Dilated Eye Examactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1150Substance Use Disorder Short Acting Medicationactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1151Substance Use Disorder Long Acting Medication Administrationactive2025-01uscms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1152Substance Use Disorder Short Acting Medication Administrationactive2024-02uscms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1155Substance Use Disorder Short Acting Medication Administrationactive2023-11ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1156Substance Use Disorder Long Acting Medication Administrationactive2021-11usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1157Substance Use Disorder Short Acting Medication Administrationactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1163Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccineactive2022-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1164Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccineactive2022-02usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1165Hospice Diagnosisactive2022-08usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1166Hospice Diagnosisactive2022-08ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1167Palliative Care Diagnosisactive2022-08usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1168Palliative Care Diagnosisactive2022-08ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1169Palliative Care Diagnosisactive2022-08usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.11.1031Hyperthyroidismactive2018-03usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.11.1033Hyperthyroidismactive2018-03ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.11.1034Hyperparathyroidismactive2022-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.11.1036Hyperparathyroidismactive2018-03usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.12.1015Hyperthyroidismactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.12.1016Hyperparathyroidismactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1170Atomoxetineactive2022-09usrx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1171Clonidineactive2024-01usrx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1172Dexmethylphenidateactive2025-01usrx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1173Dextroamphetamineactive2022-09usrx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1174Lisdexamfetamineactive2022-09usrx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1176Methylphenidateactive2024-01usrx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1177Lower Body Fractures Excluding Ankle and Footactive2022-09usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1178Lower Body Fractures Excluding Ankle and Footactive2023-07usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1179Malignant Neoplasms of Lower and Unspecified Limbsactive2022-09usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.118.11.1042Counseling for Physical Activityactive2019-03ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.118.11.1077Falls Screeningactive2018-03usloinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.118.11.1097CT Colonographyactive2019-03usloinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.118.11.1220Frailty Device SNOMEDactive2024-02ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.118.12.1028Falls Screeningactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.118.12.1035Counseling for Physical Activityactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.118.12.1300Frailty Deviceactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1180Malignant Neoplasms of Lower and Unspecified Limbsactive2023-07usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1181Mechanical Complications Excluding Upper Bodyactive2022-09usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1182Mechanical Complications Excluding Upper Bodyactive2023-07usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1183Partial Arthroplasty of Hipactive2022-09uscms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1184Partial Arthroplasty of Hipactive2023-07usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1188Removal, Revision and Supplement Procedures of the Lower Body and Spineactive2022-12uscms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1189Removal, Revision and Supplement Procedures of the Lower Body and Spineactive2023-07usvsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1190Antibiotic Medications for Upper Respiratory Infectionactive2025-01usrx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1193Malignant Neoplasmsactive2022-09usicd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1194Malignant Neoplasmsactive2022-09ussct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1196Atherosclerosis of the Extremitiesactive2023-07usvsac